TransEnterix Partners with Getz Healthcare to Lead Robotic Sales, Service and Support.
M2 PHARMA-November 10, 2016-TransEnterix Partners with Getz Healthcare to Lead Robotic Sales, Service and Support
(C)2016 M2 COMMUNICATIONS
- US-based medical device company TransEnterix, Inc. (NYSE MKT: TRXC) has expanded distribution of the Senhance surgical robotic system, the company said.
The company has partnered with Australian medical devices and equipment distributor Getz Healthcare to be the exclusive distribution partner for the Senhance in the Australian and New Zealand markets.
TransEnterix is a medical device company that is pioneering the use of robotics to improve minimally invasive surgery by addressing the clinical and economic challenges associated with current laparoscopic and robotic options.
The company is focused on the commercialisation of the Senhance Surgical Robotic System, a multi-port robotic system that brings the advantages of robotic surgery to patients while enabling surgeons with innovative technology such as haptic feedback and eye sensing camera control.
It is also developing the SurgiBot System, a single-port, robotically enhanced laparoscopic surgical platform.
The Senhance Surgical Robotic System has been granted a CE Mark but is not currently available for sale in the United States.
Getz Healthcare is a pan-Asian distributor of medical devices and equipment, with operations in nine countries across the region.
((Comments on this story may be sent to email@example.com))
|Printer friendly Cite/link Email Feedback|
|Date:||Nov 10, 2016|
|Previous Article:||Mylan reports financial results for nine months ended 30 September 2016.|
|Next Article:||Thermo Fisher Scientific, Hamilton Form Sample Storage Collaboration.|